Q: What is Royalty Pharma plc Class A Ordinary Shares's WACC?

Royalty Pharma plc Class A Ordinary Shares (RPRX) has a Weighted Average Cost of Capital (WACC) of 7.15%. This is calculated using a Cost of Equity of 8.71% (via CAPM with a beta of 1.00) and a pre-tax Cost of Debt of 3.75%, with an equity weight of 72.87% in the capital structure.

Q: Is Royalty Pharma plc Class A Ordinary Shares's WACC high or low?

Royalty Pharma plc Class A Ordinary Shares's WACC of 7.15% is below the typical range of 8-12% for most companies, indicating relatively low cost of capital and lower risk. WACC is used as the discount rate in DCF valuations — a lower WACC results in higher present values of future cash flows.

Q: How is Royalty Pharma plc Class A Ordinary Shares's WACC calculated?

Royalty Pharma plc Class A Ordinary Shares's WACC is calculated using the formula: WACC = (E/V × Re) + (D/V × Rd × (1-T)). The Cost of Equity (Re) of 8.71% is derived from the CAPM model using a beta of 1.00. The pre-tax Cost of Debt (Rd) is 3.75%. The capital structure is 72.87% equity and 27.13% debt.

Question 1

What is Royalty Pharma plc Class A Ordinary Shares's WACC?

Accepted Answer

Royalty Pharma plc Class A Ordinary Shares（RPRX） WACC 解读

Royalty Pharma plc Class A Ordinary Shares（RPRX）当前估算的 WACC 为 7.15%。其中股权成本为 8.71%，税前债务成本为 3.75%，股权权重为 72.87%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较低区间，通常意味着资本成本较低、估值折现压力更小。

Question 2

Is Royalty Pharma plc Class A Ordinary Shares's WACC high or low?

Accepted Answer

Royalty Pharma plc Class A Ordinary Shares（RPRX） WACC 解读

Royalty Pharma plc Class A Ordinary Shares（RPRX）当前估算的 WACC 为 7.15%。其中股权成本为 8.71%，税前债务成本为 3.75%，股权权重为 72.87%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较低区间，通常意味着资本成本较低、估值折现压力更小。

Question 3

How is Royalty Pharma plc Class A Ordinary Shares's WACC calculated?

Accepted Answer

Royalty Pharma plc Class A Ordinary Shares（RPRX） WACC 解读

Royalty Pharma plc Class A Ordinary Shares（RPRX）当前估算的 WACC 为 7.15%。其中股权成本为 8.71%，税前债务成本为 3.75%，股权权重为 72.87%。这个折现率可以直接作为 DCF 估值和资本结构判断的起点。

处于相对较低区间，通常意味着资本成本较低、估值折现压力更小。

Royalty Pharma plc Class A Ordinary Shares (RPRX) — WACC 分析

WACC 构成

解读

Royalty Pharma plc Class A Ordinary Shares（RPRX）WACC：7.15%

WACC计算器

Royalty Pharma plc Class A Ordinary Shares（RPRX） WACC 解读

RPRX 公司分析

RPRX DCF 估值

继续做同行对比